March 4 (Reuters) - Genetic Technologies Ltd (GTG) :
- GENETIC TECHNOLOGIES SIGNS MULTI-YEAR US DISTRIBUTION AGREEMENT FOR COVID RISK TEST
- GENETIC TECHNOLOGIES LTD - CO SIGNS CO-EXCLUSIVE PRODUCTION AND DISTRIBUTION RIGHTS AND LICENSE AGREEMENT WITH INFINITY BIOLOGIX LLC
- GENETIC TECHNOLOGIES LTD - IBX IS REQUIRED TO MAKE MINIMUM PAYMENTS TO CO TOTALING US$2.9 MILLION OVER TERM TO MAINTAIN EXCLUSIVITY
- GENETIC TECHNOLOGIES LTD - UNDERLYING ROYALTY STRUCTURE IS ON A PER UNIT BASIS OF US$10
- GENETIC TECHNOLOGIES LTD - IBX WILL DEFINE AND DECIDE SALES AND END-TO-CONSUMER PRICING STRUCTURE FOR COVID-19 RISK TEST
- GENETIC TECHNOLOGIES LTD - GTG TEAM IS IN FINAL STAGES TO SUBMIT COVID-19 RISK TEST FOR CLEARANCE FROM CLINICAL LABORATORY IMPROVEMENT AMENDMENTS
- Forums
- ASX - By Stock
- GTG
- News: GTG Genetic Technologies Signs Multi-Year US Distribution Agreement For COVID Risk Test
News: GTG Genetic Technologies Signs Multi-Year US Distribution Agreement For COVID Risk Test
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
|
|||||
Last
4.3¢ |
Change
0.002(4.88%) |
Mkt cap ! $6.252M |
Open | High | Low | Value | Volume |
4.3¢ | 4.4¢ | 4.3¢ | $7.247K | 168.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49000 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 133140 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49000 | 0.041 |
1 | 2500 | 0.040 |
2 | 295000 | 0.038 |
3 | 74000 | 0.037 |
3 | 49152 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 133140 | 2 |
0.045 | 11250 | 1 |
0.059 | 35590 | 1 |
0.060 | 6 | 1 |
0.000 | 0 | 0 |
Last trade - 15.18pm 15/08/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online